Subscribe to Breaking News emails

You have successfully subscribed to the Breaking News email.

Subscribe today to be the first to to know about breaking news and special reports.

Will Drug Prices Rise If CVS Buys Target's Pharmacy Business?

by Stephen Verdi /  / Updated 

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.

If your pharmacist wears a red polo and khakis under their labcoat, you might be about to get a better deal on your prescriptions.

CVS today announced plans to buy Target’s in-store pharmacy and clinic business for $1.9 billion. Target currently runs over 1,660 pharmacies in 47 states, plus 80 clinics. Pharmacies will be renamed "CVS/Pharmacy," while clinics will be called "MinuteClinic."

Even though CVS is buying one of its competitors, the deal shouldn't raise antitrust concerns or prices, said healthcare industry economic analyst Dr. Sumanth Addanki, because their product ranges have little overlap.

"When you have two big companies like this, their relationship with suppliers and wholesalers is bound to improve," he added. And hopefully, "they would pass some of those savings along to the consumer."

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.
MORE FROM news